Cowen analyst Doug Schenkel reiterated an Outperform rating Twist Bioscience (NASDAQ: TWST) after the company announced a partnership with Takeda ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE